AbbVie
ABBV
#30
Rank
C$559.36 B
Marketcap
C$316.60
Share price
1.02%
Change (1 day)
22.88%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): C$9.15 Billion

According to AbbVie's latest financial reports the company's current earnings are C$61.16 Billion. , an increase over its 2024 earnings that were of C$5.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 C$9.19 B77.53%
2024 C$5.17 B-40.54%
2023 C$8.70 B-53.62%
2022 C$18.77 B3.76%
2021 C$18.09 B282.25%
2020 C$4.73 B-59.67%
2019 C$11.73 B62.13%
2018 C$7.24 B-32.74%
2017 C$10.76 B-1.99%
2016 C$10.98 B18.65%
2015 C$9.25 B180.5%
2014 C$3.30 B-55.57%
2013 C$7.42 B-6.86%
2012 C$7.97 B56.05%
2011 C$5.11 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.75 B 60.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.36 B 371.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.66 B 37.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.26 B-75.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.65 B 48.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.37 B 45.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.43 B 122.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$13.94 B 51.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$1.11 B-87.89%๐Ÿ‡บ๐Ÿ‡ธ USA